Dexus’ $446 Million Acquisition Of SAHMRI 2 Clinical And Medical Research Facility

MinterEllison has advised Commercial & General. Commercial & General sold its $446 million SAHMRI 2 clinical and medical research facility (also known as the Australian Bragg…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Author: Michael Patrini

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here